Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2018 | The CLL epigenome

Elias Campo • 25 Oct 2018
ERIC 2018
Chronic Lymphocytic Leukemia Leukemia

Elias Campo, MD, PhD, of the University of Barcelona, Barcelona, Spain, discusses the pathogenesis of chronic lymphocytic leukemia (CLL), including the role of the epigenome in this process, which is becoming increasingly apparent. This interview took place at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.

More from Elias Campo

2:00
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
Elias Campo • 29 Mar 2017
3:10
Potential clinical impact of genomic analysis in CLL
Elias Campo • 27 Mar 2017

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals